Wells Fargo Downgrades uniQure BV (QURE) to Equal Weight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Mizuho Securities Downgrades uniQure BV (QURE) to Neutral
June 25, 2020 6:31 AM EDTMizuho Securities analyst Difei Yang downgraded uniQure BV (NASDAQ: QURE) from Buy to Neutral with a price target of $61.00 (from $90.00).
The analyst commented, "uniQure announced a ~$2.0 billion licensing agreement with CSL Behring for commercialization rights to AMT-061 for Hemophilia B. We... More
